Leonard Zehr, Author at BioTuesdays

Feature

CellMax developing first blood test for CRC preventative screening

Padma Sundar, VP of Strategy and Market Access By Len Zehr Closely-held CellMax Life has developed FirstSightCRC, the first blood test to identify precancerous adenomas, with accuracy similar to colonoscopies, when...

April 16, 2019

Feature

BioSig unlocking future of bioelectronic medicine through signal processing

Kenneth Londoner, Founder, Chairman and CEO By Len Zehr With the FDA’s 510(k) clearance of its PURE EP System in August 2018 and first successful patient cases, BioSig (NASDAQ:BSGM) is advancing its vision to improve...

April 9, 2019

Feature

NuPulseCV evaluating new intravascular ventricular assist system

By Len Zehr Closely-held NuPulseCV is enrolling patients with advanced heart failure in a feasibility study with its intravascular ventricular assist system (iVAS), a minimally invasive heart pump designed to allow...

April 2, 2019

Feature

Vessi Medical developing new treatment for superficial bladder cancer

By Len Zehr Closely-held Vessi Medical wants to change the standard of care for superficial bladder cancer by using a surface cryotherapy approach in a minimally invasive in-office treatment alternative to surgery. “We...

March 26, 2019

Feature

Corindus banking on telerobotics potential to treat stroke

By Len Zehr After recently conducting five first-in-man coronary stent procedures robotically in India, Corindus Vascular Robotics (NASDAQ:CVRS) plans to perform its first remote vascular cases in the U.S. in mid-2019...

March 19, 2019

Feature

DxTerity bringing at-home precision medicine to patients with autoimmune diseases

By Len Zehr Closely-held DxTerity has developed the first affordable diagnostics platform for at-home monitoring of autoimmune disease activity and response to drug treatment, with tests that use longitudinal gene...

March 12, 2019

Feature

In Conversation with Gregory Montalbano of MIDI

By Len Zehr As a principal of closely-held MIDI Medical Product Development, Greg Montalbano has a unique background in industrial design, usability/ergonomics and manufacturing with over 25 years of experience...

March 5, 2019

Feature

PharmaJet injection devices creating needle-free world

By Len Zehr Closely-held PharmaJet’s needle-free injection devices have the potential to rapidly improve the delivery of vaccines in emerging markets as well as pharmaceuticals currently under development. “We are at...

February 26, 2019

Feature

Lineagen champions clinical information solutions for autism spectrum disorders and other neurodevelopmental conditions

By Len Zehr Closely-held Lineagen has developed and commercialized a comprehensive portfolio of behavioral screening and genetic tests for autism spectrum disorders (ASD) and other forms of childhood neurodevelopmental...

February 19, 2019

Feature

ImpediMed sees revenue upswing from new SaaS business model

ImpediMed’s (ASX:IPD) transition to a software-as-a-service (SaaS) subscription business model in 2018, in conjunction with the introduction of the SOZO Digital Health Platform, is already paying off on the top line.

February 12, 2019

Author - Leonard Zehr

CellMax developing first blood test for CRC preventative screening

BioSig unlocking future of bioelectronic medicine through signal processing

NuPulseCV evaluating new intravascular ventricular assist system

Vessi Medical developing new treatment for superficial bladder cancer

Corindus banking on telerobotics potential to treat stroke

DxTerity bringing at-home precision medicine to patients with autoimmune diseases

In Conversation with Gregory Montalbano of MIDI

PharmaJet injection devices creating needle-free world

Lineagen champions clinical information solutions for autism spectrum disorders and other neurodevelopmental conditions

ImpediMed sees revenue upswing from new SaaS business model

General

More